Startseite Medizin Vitamin C and aberrant electrolyte results
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Vitamin C and aberrant electrolyte results

  • Qing H. Meng , William C. Irwin und Kishore Visvanathan
Veröffentlicht/Copyright: 21. September 2011

Abstract

Vitamin C interferes with assays involving the redox-reaction. However, the interference of Vitamin C with electrolytes has not been reported. In the present case, we describe a 61-year-old lady with severe electrolyte abnormalities after administration of high doses of vitamin C. This patient, who had terminal colon cancer, presented to hospital with anuria. Her electrolytes were extremely abnormal (determined on the Beckman Synchron LX20): serum sodium 200mmol/L, potassium 7.0mmol/L, and chloride 50mmol/L. Repeated measurements showed similar abnormalities. However, these critical abnormalities did not fit her clinical picture, as she was alert with normal vital signs. One of the specimens was also run on both the ABL700 and the Bayer644 analyzers, and the electrolytes appeared normal. Pooled serum from healthy individuals to which various amounts of vitamin C was added then was analyzed on Beckman Synchron LX20 for electrolytes, demonstrating the interference of vitamin C consistent with the initial finding. Thus, we eventually figured out that the aberrant results were due to the vitamin C caused analytical interference.


Corresponding author: Dr. Qing H. Meng, Department of Pathology, Room 4917, Royal University Hospital, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK, S7N 0W8, Canada Phone: +1-306-655-2165, Fax: +1-306-655-2193,

References

1 Pauling L. Evolution and the need for ascorbic acid. Proc Natl Acad Sci USA 1970; 67: 1643–8. 10.1073/pnas.67.4.1643Suche in Google Scholar PubMed PubMed Central

2 Englard S, Seifter S. The biochemical functions of ascorbic acid. Annu Rev Nutr 1986; 6: 365–406. 10.1146/annurev.nu.06.070186.002053Suche in Google Scholar PubMed

3 Badrick TC, Campbell B. Effects of intravenous infusion of ascorbate on common clinical chemistry tests. Clin Chem 1992; 38: 2160. 10.1093/clinchem/38.10.2160aSuche in Google Scholar

4 Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994; 40: 1996–2005. 10.1093/clinchem/40.11.1996Suche in Google Scholar

5 White-Stevens RH, Stover LR. Interference by ascorbic acid in test systems involving peroxidase. II. Redox-coupled indicator systems. Clin Chem 1982; 28: 589–95. Suche in Google Scholar

6 Spencer K. Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 1986; 23: 1–25. 10.1177/000456328602300101Suche in Google Scholar PubMed

7 Siest G, Appel W, Blijenberg GB, Capolaghi B, Galteau MM, Heusghem C, et al. Drug interference in clinical chemistry: studies on ascorbic acid. J Clin Chem Clin Biochem 1978; 16: 103–10. 10.1515/cclm.1978.16.2.103Suche in Google Scholar PubMed

8 Freemantle J, Freemantle MJ, Badrick T. Ascorbate inter-ferences in common clinical assays performed on three analyzers. Clin Chem 1994; 40: 950–1. 10.1093/clinchem/40.6.950Suche in Google Scholar

9 Zoppi F, Fenili D. Drug interferences in reactions for detecting hydrogen peroxide by means of peroxidase. Clin Chem 1980; 26: 1229–30. 10.1093/clinchem/26.8.1229Suche in Google Scholar

10 Pesce MA, Bodourian SH. Interference with the enzymic measurement of cholesterol in serum by use of five reagent kits. Clin Chem 1977; 23: 757–60. 10.1093/clinchem/23.4.757Suche in Google Scholar

11 Moshides JS. Comparison of ascorbic acid interference in HDL-cholesterol estimation by six precipitation methods, with use of a sensitive enzymic cholesterol reagent. Clin Chem 1987; 33: 1467–8. 10.1093/clinchem/33.8.1467aSuche in Google Scholar

Published Online: 2011-9-21
Published in Print: 2005-4-1

© by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
  2. Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
  3. Fucosylation of serum glycoproteins in lung cancer patients
  4. Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
  5. α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
  6. The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
  7. Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
  8. Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
  9. Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
  10. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
  11. An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
  12. Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
  13. Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
  14. Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
  15. Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
  16. Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
  17. Vitamin C and aberrant electrolyte results
  18. POX-ACT assay and d-ROMs test: comparison impossible
  19. A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
Heruntergeladen am 30.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.080/pdf
Button zum nach oben scrollen